Primary Antibodies

View as table Download

Her2 (ERBB2) Human Monoclonal Antibody [Clone ID: 4D5-8 (trastuzumab)]

TA385652

USD 523.00

2 Weeks

Recombinant Anti-erbB-2 (Her-2/neu) (Clone 4D5-8 (trastuzumab))

Applications	ELISA, FC, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD3E Mouse Monoclonal Antibody [Clone ID: OKT-3 (muromonab)]

TA385685

USD 523.00

2 Weeks

Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))

Applications	FC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD52 Human Monoclonal Antibody [Clone ID: Campath-1H]

TA385689

USD 523.00

2 Weeks

Recombinant Anti-CD52 (Clone Campath-1H)

Applications	ELISA, FC, IHC, WB
Reactivities	Human, Monkey
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD20 (MS4A1) Human Monoclonal Antibody [Clone ID: 10F381 (rituximab)]

TA385692

USD 523.00

2 Weeks

Recombinant Anti-CD20 (Clone 10F381 (rituximab))

Applications	FC
Reactivities	Human, Monkey
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

IL2 Receptor alpha (IL2RA) Human Monoclonal Antibody [Clone ID: Daclizumab]

TA385810

USD 523.00

2 Weeks

Recombinant Anti-IL-2R (Clone Daclizumab)

Applications	FC
Reactivities	Human, Monkey
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

EGFR Human Monoclonal Antibody [Clone ID: C225 (Cetuximab)]

TA385847

USD 523.00

2 Weeks

Recombinant Anti-EGFR (Clone C225 (Cetuximab))

Applications	FC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

TAG72 Mouse Monoclonal Antibody [Clone ID: B72.3 (Satumomab)]

TA385849

USD 523.00

2 Weeks

Recombinant Anti-Tumor associated glycoprotein (TAG) 72 (Clone B72.3 (Satumomab))

Applications	FC, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CEA Human Monoclonal Antibody [Clone ID: Arcitumomab]

TA385851

USD 523.00

2 Weeks

Recombinant Anti-carcinoembryonic antigen (CEA) (Clone Arcitumomab)

Applications	FC, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

CD40L (CD40LG) Human Monoclonal Antibody [Clone ID: hu5c8 (Ruplizumab)]

TA385961

USD 523.00

2 Weeks

Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))

Applications	FC, WB
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

TNF alpha (TNF) Human Monoclonal Antibody [Clone ID: CDP 571 (Humicade)]

TA385965

USD 523.00

2 Weeks

Recombinant Anti-TNF alpha (Clone CDP 571 (Humicade))

Applications	ELISA
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Integrin alpha 5 (ITGA5) Human Monoclonal Antibody [Clone ID: M200 (Volociximab)]

TA385968

USD 523.00

2 Weeks

Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))

Applications	ELISA, FC, IF, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

VEGFA Human Monoclonal Antibody [Clone ID: Bevacizumab]

TA386066

USD 523.00

2 Weeks

Recombinant Anti-VEGF (Clone Bevacizumab)

Applications	ELISA, FC, IP, WB
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Integrin alpha 4 (ITGA4) Human Monoclonal Antibody [Clone ID: Natalizumab]

TA386070

USD 523.00

2 Weeks

Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)

Applications	FC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

TNF alpha (TNF) Human Monoclonal Antibody [Clone ID: D2E7 (Adalimumab)]

TA386072

USD 523.00

2 Weeks

Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))

Applications	ELISA, IF, IHC
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

IL6R Human Monoclonal Antibody [Clone ID: rhPM-1 (Tocilizumab)]

TA386091

USD 523.00

2 Weeks

Recombinant Anti-IL-6 receptor (Clone rhPM-1 (Tocilizumab))

Applications	ELISA
Reactivities	Human
Conjugation	Unconjugated
Modifications	NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Active filters

Modifications

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Edit Clear

Filter by

Target Symbol

Choose Multiple...

Reactivities

Choose Multiple...

Applications

Choose Multiple...

Antibody Hosts

Choose Multiple...

Isotypes

Choose Multiple...

Antibodies

Primary Antibodies

TNF

CD3E

CD40LG

CD52

CEA

EGFR

ERBB2

IL2RA

IL6R

ITGA4

ITGA5

MS4A1

TAG72

VEGFA

Human

Monkey

ELISA

IHC

Human

Mouse

IgG1, kappa

IgG2a, kappa

Monoclonal

Unconjugated

Unmodified

Phospho-specific

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques.

Phospho S83

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques.

This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques.

Acetyl K5

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

Modification

Phospho S15

Phospho S166

Phospho S376

Phospho T286

This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

Acetyl K12

Acetyl K16

Acetyl K27

Acetyl K36

Acetyl K4

MonoMethyl K342

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

Phospho S104

Phospho S127

Phospho S128

Phospho S129

Phospho S139

Phospho S16

Phospho S176/180

Phospho S21

Phospho S319

Phospho S345

Phospho S366

Phospho S37

Phospho S380

Phospho S39

Phospho S396

Phospho S56

Phospho S616

Phospho S727

Phospho S795

Phospho S89

Phospho S9

Phospho T183/T172

Phospho T187

Phospho T389

Phospho T514

Phospho Y410

Phospho Y779

Phospho Y925

This chimeric hamster (Armenian) antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques.

This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column.

This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques.

This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

TriMethyl K56

Acetyl K14

Acetyl K15

Acetyl K18

Acetyl K23

Acetyl K262/K265/K274

Acetyl K29

Acetyl K332

Acetyl K56

Acetyl K8

Acetyl K9

Acetyl K9/K14/K18/K23/K27

Acetyl K91

Asymmetric DiMethyl R3

DiMethyl K385

K11-linkage Specific Polyubiquitin

K27-linkage Specific Polyubiquitin

K29-linkage Specific Polyubiquitin

K33-linkage Specific Polyubiquitin

K48-linkage Specific Polyubiquitin

K6-linkage Specific Polyubiquitin

K63-linkage Specific Polyubiquitin

M1-linkage Specific Polyubiquitin

MonoMethyl K36

MonoMethyl K5

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

Pan Acetyl-Lysine

Pan DiMethyl-lysine

Pan Phospho-Tyrosine

Phospho 180/Y182,Phospho T180/Y182,Phospho T180/Y182,Phospho T183/Y1845

Phospho Phospho S87

Phospho S1

Phospho S10

Phospho S10/T11

Phospho S102

Phospho S1033

Phospho S11

Phospho S1105

Phospho S1108

Phospho S112

Phospho S1177

Phospho S1248

Phospho S1387

Phospho S1490

Phospho S157

Phospho S16/T17

Phospho S17

Phospho S172

Phospho S176

Phospho S180

Phospho S182

Phospho S189,Phospho S207

Phospho S19

Phospho S194

Phospho S1943

Phospho S1981

Phospho S199/S204

Phospho S2

Phospho S20

Phospho S202

Phospho S2056

Phospho S209

Phospho S211

Phospho S2152

Phospho S217

Phospho S22

Phospho S235/236

Phospho S240/244

Phospho S241

Phospho S243

Phospho S2448

Phospho S2481

Phospho S253

Phospho S257

Phospho S257/T261

Phospho S259

Phospho S271

Phospho S271/T275

Phospho S28

Phospho S280

Phospho S29/33/37/T41

Phospho S291

Phospho S293

Phospho S294

Phospho S296

Phospho S298

Phospho S299

Phospho S304

Phospho S307

Phospho S308,Phospho S309,Phospho S305

Phospho S32

Phospho S32/S36

Phospho S320

Phospho S323

Phospho S326

Phospho S33

Phospho S33/35

Phospho S33/S37/T41

Phospho S330

Phospho S334

Phospho S338

Phospho S358

Phospho S36

Phospho S365

Phospho S380/T382/383

Phospho S386

Phospho S392

Phospho S397

Phospho S4/S8

Phospho S40

Phospho S409/S410

Phospho S412

Phospho S420

Phospho S422

Phospho S423/S425

Phospho S425

Phospho S428

Phospho S445

Phospho S448

Phospho S45

Phospho S455

Phospho S46

Phospho S465/467 + S423/425

Phospho S465/S467

Phospho S467

Phospho S471/472

Phospho S473

Phospho S473,Phospho S474,Phospho S472

Phospho S474

Phospho S483

Phospho S485

Phospho S5

Phospho S505

Phospho S507

Phospho S51

Phospho S516

Phospho S519/T522

Phospho S529

Phospho S552

Phospho S555

Phospho S563

Phospho S588

Phospho S6

Phospho S608

Phospho S611/615

Phospho S611/615/616

Phospho S612

Phospho S615

Phospho S62

Phospho S621

Phospho S63

Phospho S636/639

Phospho S637

Phospho S638

Phospho S641

Phospho S643/676

Phospho S645

Phospho S65

Phospho S657/Y658

Phospho S660

Phospho S668

Phospho S675

Phospho S7

Phospho S70

Phospho S71

Phospho S728

Phospho S73

Phospho S744/748

Phospho S757

Phospho S80

Phospho S807/811

Phospho S811

Phospho S82

Phospho S838/S840

Phospho S845

Phospho S886

Phospho S890

Phospho S896/S897

Phospho S897

Phospho S916

Phospho S932

Phospho S957

Phospho S967

Phospho Ser15

Phospho Ser198/Ser199/Ser202

Phospho Ser355

Phospho Ser404

Phospho Ser416

Phospho Ser551

Phospho Ser729

Phospho Ser792

Phospho Ser90

Phospho T11

Phospho T117

Phospho T14

Phospho T1462

Phospho T156

Phospho T163

Phospho T17

Phospho T172

Phospho T179

Phospho T18

Phospho T18/S19

Phospho T180/T183

Phospho T180/Y182

Phospho T180/Y182 + T183/Y1845

Phospho T181

Phospho T183/Y185

Phospho T183/Y185,Phospho T221/Y223

Phospho T184/T187

Phospho T186

Phospho T189

Phospho T197

Phospho T197/202

Phospho T1989

Phospho T199

Phospho T202/Y204 + T185/Y187

Phospho T202/Y204+T185/Y187

Phospho T204

Phospho T210

Phospho T212

Phospho T217

Phospho T23

Phospho T231

Phospho T231/S232

Phospho T232

Phospho T235

Phospho T24,Phospho T32,Phospho T28

Phospho T246

Phospho T261

Phospho T288

Phospho T288,Phospho T232,Phospho T198

Phospho T292

Phospho T3

Phospho T308

Phospho T32

Phospho T320

Phospho T334

Phospho T346

Phospho T357/S358/S360

Phospho T359

Phospho T359/S363

Phospho T37/46

Phospho T384

Phospho T387

Phospho T395

Phospho T410

Phospho T421/S424

Phospho T434

Phospho T446

Phospho T45

Phospho T495

Phospho T498

Phospho T505

Phospho T508/T505

Phospho T538

Phospho T543

Phospho T56

Phospho T567,Phospho T564,Phospho T558

Phospho T573

Phospho T58

Phospho T581

Phospho T6

Phospho T641

Phospho T642

Phospho T668

Phospho T669

Phospho T678

Phospho T69/71

Phospho T69/T71

Phospho T696

Phospho T70

Phospho T81

Phospho T845

Phospho T853

Phospho T91

Phospho T918

Phospho T93

Phospho T982

Phospho Thr212/Ser214

Phospho Thr421

Phospho Y10

Phospho Y1007

Phospho Y1007/1008

Phospho Y1008

Phospho Y1018

Phospho Y1020

Phospho Y1021

Phospho Y1022/1023

Phospho Y1045

Phospho Y1054/1055

Phospho Y1068

Phospho Y1070

Phospho Y1086

Phospho Y1096

Phospho Y1148

Phospho Y1165/1166,Phospho Y1189/1190

Phospho Y1173

Phospho Y1175

Phospho Y1189/Y1190,Phospho Y1165/Y1166

Phospho Y1217

Phospho Y1221/1222

Phospho Y1234/1235

Phospho Y1248

Phospho Y1284

Phospho Y133

Phospho Y1349

Phospho Y1361

Phospho Y138

Phospho Y139

Phospho Y14

Phospho Y145

Phospho Y1474

Phospho Y15

Phospho Y165

Phospho Y171

Phospho Y177

Phospho Y182

Phospho Y191

Phospho Y204

Phospho Y207

Phospho Y216

Phospho Y221

Phospho Y232

Phospho Y245

Phospho Y284

Phospho Y291

Phospho Y292

Phospho Y307

Phospho Y311

Phospho Y317

Phospho Y322

Phospho Y323

Phospho Y340

Phospho Y353

Phospho Y397

Phospho Y402

Phospho Y412

Phospho Y416

Phospho Y416/Y416

Phospho Y467/Y199/Y464

Phospho Y564

Phospho Y576/577

Phospho Y589/591

Phospho Y594

Phospho Y653

Phospho Y659

Phospho Y674/675 + Y706/707

Phospho Y694

Phospho Y699

Phospho Y700

Phospho Y705

Phospho Y708

Phospho Y719

Phospho Y723

Phospho Y724

Phospho Y731

Phospho Y751

Phospho Y754

Phospho Y759

Phospho Y771

Phospho Y789

Phospho Y792

Phospho Y845

Phospho Y849

Phospho Y869

Phospho Y980/981

Phospho Y992

Phospho Y996

Phospho Y998

Phospho pS221

Phospho s724

Phospho-(Ser/Thr)

Phospho-PKC (pan) (βII Ser660)

Phospho-RPS6KB1-S371

This chimeric human antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Chicken scFv format, for improved compatibility with existing reagents, assays and techniques.

This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Chicken scFv format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created to reduce immunogenicity during in vivo applications.

This is a chimeric human antibody, based on the original mouse IgG2a format, created for improved compatibility with existing reagents, assays and techniques.

This is a chimeric mouse antibody, based on the original hamster IgG format, created for improved compatibility with existing reagents, assays and techniques.

This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques.

This is a chimeric recombinant Fab fragment created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls.

This is a recombinant chimeric Fab fragment created as part of a panel offering antibodies of the same specificity in different formats (species, isotype, subtype and modified versions) for use as isotype controls.

This is a reformatted human IgG1 antibody based on the therapeutic Fab fragment. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

This is a reformatted mouse IgG1 antibody, based on the original mouse IgG2a format, created for improved compatibility with existing reagents, assays and techniques.

This reformatted antibody was made using the variable domain sequences of the original mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This reformatted antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques.

Ubiquityl K119

Unconjugated

citrulline R2/R8/R17

monoMethyl E105

pan Phospho-Serine/Threonine

pan Symmetric-DiMethyl-Arginine

pan-Di-Methyl K

pan-Mono-Methyl K

pan-Mono-MethylR（R*GG）

pan-Myristyl-G

pan-Phospho-Serine

pan-TriMethyl-lysine

pan-tri-Methyl K

phospho S76

phospho T1079,Phospho T1041

succinylation K79

Indirect

HT BioMarker Screening/Drug Discovery

CAR T-cell

Neuroscience

Primary Antibodies

Active filters

Modifications

Filter by

Category

Target Symbol

Reactivities

Applications

Antibody Hosts

Isotypes

Clonalities

Conjugates

Assay Types

Viral Gene Delivery

ELISA Center

Other Tools

Hot Topics

HT BioMarker Screening/Drug Discovery

CAR T-cell

Oncology

Virus

Signal Transduction

Technology

Who we are

Company News

Careers

Primary Antibodies

Active filters

Modifications

Filter by

Category

Target Symbol

Reactivities

Applications

Antibody Hosts

Isotypes

Clonalities

Conjugates

Assay Types

Category

SubCategory

Target Symbol

Species

Reactivities

Applications

Antibody Hosts

Isotypes

Clonalities

Conjugates

Carrier-free

Knockout (KO) Validation

Recombinant

Expression Hosts

Biosimilar

Lentivirus

Tags

Vectors

Reporters

Modifications

Protein Source

Mutants

Assay Types

Assay Platforms

Disease States

Diagnosis

Tissues

TissueScan Types

QC Levels

C-Tag

Mammalian Cell Selection

Families

Pathways

Brands

Citations

Availabilities

__Category ID

__Matched ELISA Pair

__PT